Gujarat Kidney And Super Speciality Limited (NSE:GKSL)
India flag India · Delayed Price · Currency is INR
127.21
+0.17 (0.13%)
At close: Jul 31, 2026

NSE:GKSL Financials Overview

Millions INR. Fiscal year is Apr - Mar.

Revenue & Profits

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Revenue
820.13820.13402.4247.74-7.86
Revenue Growth
103.80%103.80%742.89%---28.71%
Gross Profit
592.58592.58273.2833.42-7.38
Operating Income
222.4222.4132.5716.32-0.041.44
Net Income
154.97154.9794.1317.14-0.060.98
Earnings Per Share
2.492.491.850.49-0.000.03
EPS Growth
34.94%34.94%276.81%--19.50%

Cash & Debt

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash & Investments
132.82132.8225.969.70.040.03
Total Debt
291.09291.0983.0958.65--
Net Cash (Debt)
-158.27-158.27-57.13-48.950.040.03
Net Cash Growth
----5.13%221.47%
Net Cash Per Share
-2.54-2.54-1.12-1.400.000.00

Cash Flow & CapEx

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Operating Cash Flow
-38.62-38.62136.0812.1300.02
Capital Expenditures
-698.14-698.14-111.16---
Free Cash Flow
-736.76-736.7624.9212.1300.02
Free Cash Flow Growth
--105.47%700940.46%-92.56%-

Margins

Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingMar '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Gross Margin
72.25%72.25%67.91%70.00%-93.89%
Operating Margin
27.12%27.12%32.94%34.17%-18.32%
Pretax Margin
25.89%25.89%31.72%47.51%-17.14%
Profit Margin
18.90%18.90%23.39%35.90%-12.53%
FCF Margin
-89.83%-89.83%6.19%25.40%-0.30%

Valuation

Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
PE Ratio
51.1351.56----
PS Ratio
12.249.74----